X-130409363-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_016024.4(RBMX2):c.280G>A(p.Val94Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,207,221 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016024.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111446Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33644
GnomAD3 exomes AF: 0.0000112 AC: 2AN: 178774Hom.: 0 AF XY: 0.0000154 AC XY: 1AN XY: 64726
GnomAD4 exome AF: 0.00000913 AC: 10AN: 1095775Hom.: 0 Cov.: 29 AF XY: 0.0000111 AC XY: 4AN XY: 361259
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111446Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33644
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.280G>A (p.V94I) alteration is located in exon 4 (coding exon 4) of the RBMX2 gene. This alteration results from a G to A substitution at nucleotide position 280, causing the valine (V) at amino acid position 94 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at